BridgeMD
New treatment option for Lateral Epicondylitis (Tennis Elbow)
Official title Comparison of Extracorporeal Shock Wave Therapy and Low-Level Laser Therapy in Patients With Lateral Epicondylitis
ClinicalTrials.gov ID: NCT07564713
What this study is testing
- What it's testing
- Background: Lateral epicondylitis is a common musculoskeletal condition characterized by pain and functional impairment of the elbow, often associated with degenerative changes in the common extensor tendon. Extracorporeal shock wave therapy (ESWT) and low-level laser therapy (LLLT) are widely used noninvasive treatment modalities; however, comparative evidence regarding their clinical and structural effects remains limited.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Clinical diagnosis of lateral epicondylitis based on physical examination findings
- Symptom duration of at least 6 weeks
- Presence of lateral elbow pain aggravated by wrist extension and/or gripping activities
- Ability to understand and comply with study procedures
- Provision of written informed consent
You likely can't join if
- Previous surgery involving the affected elbow
- History of corticosteroid or other injection therapy to the affected elbow within the last 6 months
- Presence of inflammatory rheumatic diseases (e.g., rheumatoid arthritis)
- Neurological disorders affecting the upper extremity
- Systemic inflammatory or metabolic diseases that may affect tendon structure or healing
- Cervical radiculopathy or other causes of referred upper extremity pain
See the full eligibility criteria
- Clinical diagnosis of lateral epicondylitis based on physical examination findings
- Symptom duration of at least 6 weeks
- Presence of lateral elbow pain aggravated by wrist extension and/or gripping activities
- Ability to understand and comply with study procedures
- Provision of written informed consent
- Previous surgery involving the affected elbow
- History of corticosteroid or other injection therapy to the affected elbow within the last 6 months
- Presence of inflammatory rheumatic diseases (e.g., rheumatoid arthritis)
- Neurological disorders affecting the upper extremity
- Systemic inflammatory or metabolic diseases that may affect tendon structure or healing
- Cervical radiculopathy or other causes of referred upper extremity pain
- Pregnancy or breastfeeding
- Use of anticoagulant therapy or bleeding disorders
- Severe comorbid conditions that may interfere with participation
The study team makes the final eligibility decision.
Where it's taking place
- Çorum, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Çorum, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.